the Trade name
the International unlicensed name
Is not present
the Dosage form
Spray for topical administration
100 ml of drug contain
dekvaliniya chloride of 0.1 g, tyrothricin of 0.4 g, β-glitsirretovy acid of 0.06 g, Hydrocortisoni acetas of 0.06 g, lidocaine hydrochloride of 0.1 g,
excipients: propylene glycol, oil pineapple, sodium saccharinate, ethanol of 96%.
Transparent, colourless or light yellow solution with characteristic taste and a smell of pineapple.
Drugs for treatment of diseases of a respiratory system. Drugs for treatment of diseases of a throat.
ATX R02A code.
Pharmacokinetics Drug properties it is intended for inhalation use and forms therapeutic concentration, mainly, in the inflammation center.
of Anginovag combines substances of anti-inflammatory, analgetic, antibacterial, antiseptic and antiviral action in the structure. Combination of the specified pharmacological properties provides complex pathogenetic therapy of inflammatory diseases of upper airways and a mucous membrane of an oral cavity. Drug is provided in the form of spray with the valve for dispersion thanks to what it is convenient for use at treatment of infections of a stomatopharynx.
– topical treatment in infectious and inflammatory diseases of an oral cavity and upper airways: tonsillitis, pharyngitis, laryngitis, aphthous and ulcer stomatitises, glossitis.
The route of administration and doses
to Adults and children are more senior than 13 years.
Before use to rinse a mouth and a throat, to remove a plaque from affected areas.
The shock dose on 1-2 injections each 2-3 hours supporting – on 1 injection each 6 hours. The course of treatment is defined by the doctor individually, usually makes 5-7 days.
For the correct use it is recommended to place a bottle in vertical position that the oral applicator was directed to a defeat zone, but not completely you enter into an oral cavity. Press an upper part of a cap from top to down. Do not remove the oral applicator from a bottle after installation and use.
– allergic reactions to drug components
– burning sensation, dryness
– slight numbness.
– the increased individual sensitivity to any of drug components
– children’s age up to 13 years.
simultaneous use with novocaine, sedative drugs is not recommended.
89.385% of ethanol contain special indications of Anginovag in final volume. Each injection contains about 0.075 g of ethanol which can be the reason of risk use in pediatrics up to 13 years, pregnant women and patients with liver diseases, alcoholism, epilepsy, injuries of a brain therefore to apply with care.
It is necessary to be careful at appointment as the patient with diabetes as drug contains sodium saccharinate.
Pregnancy and the period of a lactation
Use of drug during pregnancy and a lactation is not contraindicated, but the expediency of reception is established by the doctor depending on advantage of advantage over potential risk of use. Not to exceed the recommended doses.
Features of influence on ability to run motor transport or other potentially dangerous mechanisms
Considering the maintenance of 0.075 g of ethanol it is necessary to be careful at control of motor transport or other potentially dangerous mechanisms.
Cases of overdose are not registered.
The form of release and packing
On 20 ml of drug place in the bottles of white color from polyethylene of high density corked by a polypropylene cover.
On 1 bottle together with a nozzle and the instruction for medical use in the state and Russian languages place in a cardboard pack.
To Store storage conditions at a temperature not above 30ºC.
To store out of children’s reach!
not to apply a period of storage after an expiration date.
the Name and the country of the manufacturing organization
Ferrer Internasional S.A.,
VIA de Carlos Gran III, 94 08028 Barcelona, Spain.
Name and country of the owner of the registration certificate
of Laboratorii Novag S.A. Spain
Name and country of the organization packer
Ferrer Internasional S.A., Spain.